In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.
[audio:https://www.audiomedica.com/podcasting/aha2005/Milton_Packer.mp3]
Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results 5 Sep, 2007 COMMENTS 16 Nov, 2005 Enoxaparin Shows Safety in Angioplasty – STEEPLE Study 12 Sep, 2005 
GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins 16 Nov, 2012 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014